Investors - Press Releases
|View printer-friendly version|
Tabula Rasa HealthCare Supports Legislation Establishing Medication Risk Prevention Program for NJ Medicaid
Dr. Knowlton’s testimony demonstrated the cost savings TRHC’s Enhanced Medication Management Program (EMTM) provides. “When we apply our Economic, Clinical and Humanistic Outcomes (ECHO) model of Enhanced Medication Therapy Management (EMTM) programs for government sponsored-plans, we estimate that a Medicaid Enhanced MTM program like ours in New Jersey will generate annual cost savings in excess of $80 million.”
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, pharmacist providers and other healthcare organizations. For more information, visit TRHC.com.
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the
|TRHC Media Contact
T: (856) 912-5714
|TRHC Investor Contact
T: (866) 648-2767
T: (215) 870-0829
Source: Tabula Rasa HealthCare, Inc.